N/A N=32 Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT
Breast Cancer
Primary: Success Rate — 65.4 percentage of participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=236 Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial
Obesity · Labor Induction · Cesarean Delivery
Primary: Number of Participants With a Need for Cesarean Delivery — 51; 53 Participants
N/A N=5 OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation
Atrial Fibrillation
Primary: Feasibility of a Tethered OFDI Capsule in Patients With Atrial Fibrillation Following RF Ablation That Swallow the OFDI Capsule — 1 Participants
N/A N=94 In-use Study of Four Different Tampons
Menstruation
Primary: Tolerance of Tampon Wear Via Physician Assessment of Vaginal Health — 0; 0; 0; 0 Participants
Phase 2 N=14 Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL
Chronic Lymphocytic Leukemia
Primary: Overall Response Rate as Defined as the Number of Patients Who Experience a Response (Complete or Partial) to Treatment at the Time of Best Response — 12 Participants
Phase 2 N=75 Probing the Synergistic Effect of Pre-Biotics & Iron Fortificants in Anemic Subjects
Iron-deficiency
Primary: Change in Hemoglobin Concentration From Baseline to 90 Days — 11.44; 11.58; 11.54; 11.61 g/dL
Phase 1 N=30 The Efficacy of Doxazosin for Cocaine Users
Cocaine Dependence
Primary: Cocaine Negative Urines — 10; 35; 14 percentage of cocaine-negative urines
Phase 4 N=826 An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Irritable Bowel Syndrome With Constipation · Chronic Idiopathic Constipation
Primary: Number of Participants With Positive Treatment-Related Anti-Drug Antibodies (ADA) in Serum — 3; 1 Participants
N/A N=35 SpO2 Validation of Noninvasive Red Diamond Disposable Pulse Oximeter Sensor
Healthy
Primary: Accuracy of Red Diamond Disposable Pulse Oximeter Sensor by Arms Calculation — 1.16 percent of oxygen saturated hemoglobin
N/A N=84 Conventional Surgery vs. Verion/VerifEye
Cataract · Astigmatism
Primary: Residual Refractive Cylinder — 0.28; 0.33 Diopters
Phase 4 N=66 IV Acetaminophen for Acute Post Operative Pain in C-Section Patients
Post-operative Pain
Primary: Opioid Requirements in Cesarean Section (C-section) Patient Population — 44; 48; 58; 57 mg
Phase 2 N=65 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
Psoriasis
Primary: Number of Participants With Serious Adverse Events (SAEs) and Non-SAEs — 0; 1; 1; 8 Participants
Phase 1 N=48 Cardiac Safety Evaluation of P03277
Healthy Volunteers
Primary: Change-from-baseline Mean Effect of P03277 on QT Interval Expressed as QTc According to Fridericia's Formula (∆QTcF) — 0.97; 5.05; 0.24; -0.11 milliseconds
Phase 3 N=1,208 Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris
Acne Vulgaris
Primary: Investigator Global Assessment (IGA) Success Rate at Week 12 — 180; 116 Participants
Phase 3 N=428 Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
Opioid Use Disorders
Primary: Response Rate, Denoted by Response Rate (Weeks 1-24). — 31; 37; 184; 176 Participants — p=<0.001